SRZN
SRZN
NASDAQ · Biotechnology

Surrozen Inc

$22.80
+1.55 (+7.29%)
As of Feb 8, 2:05 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 55.50M 49.01M 58.73M
Net Income -3,521,463 -2,802,997 -4,374,334
EPS
Profit Margin -6.3% -5.7% -7.5%
Rev Growth +7.8% +7.4% -1.1%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 86.95M 78.39M 78.23M
Total Equity 98.70M 95.79M 82.86M
D/E Ratio 0.88 0.82 0.94
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -5,026,082 -4,562,575 -6,395,991
Free Cash Flow -3,518,270 -4,055,082 -5,438,545